Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Liu

Showing results (241-250 of 252) with videos related to

Pageof 26
Sort By:
ACS Medicinal Chemistry Letters|October 18, 2023
Design and Optimization of Novel Competitive, Non-peptidic, SARS-CoV-2 M<sup>pro</sup> InhibitorsLeon Jacobs, Aletta van der Westhuyzen, Nicole Pribut, et al.
Journal of Gastroenterology and Hepatology|August 28, 2022
Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort studyDavid Stephen Prince, Glen Schlaphoff, Scott Anthony Davison, et al.
Hepatology International|August 25, 2022
Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort studyKurvi Patwala, David Stephen Prince, Yael Celermajer, et al.
Journal of Translational Medicine|January 10, 2024
Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesisXin Tracy Liu, Yu Huang, Da Liu, et al.
Cell|May 16, 2017
Metabolic Phenotypes of Response to Vaccination in HumansShuzhao Li, Nicole L Sullivan, Nadine Rouphael, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 28, 2023
The incidence of adverse outcome in donors after living donor liver transplantation: A meta-analysis of 60,829 donorsJieling Xiao, Rebecca Wenling Zeng, Wen Hui Lim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2023
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and AdultsAndrew W Lee, Ken Liu, Edouard Lhomme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2025
Discovery of BMS-986365, a first-in-class dual androgen receptor ligand-directed degrader (AR LDD) and antagonist, for the treatment of advanced prostate cancerSurendra Nayak, John D Norris, Massimo Ammirante, et al.
Movement Disorders Clinical Practice|May 2, 2024
Improving Conversations about Parkinson's DementiaIvelina Dobreva, Joanne Thomas, Anne Marr, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 8, 2018
Territory-wide population-based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong KongYee Tak Hui, Grace L H Wong, James Y Y Fung, et al.
Pageof 26

Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
ACS Medicinal Chemistry Letters|October 18, 2023
Design and Optimization of Novel Competitive, Non-peptidic, SARS-CoV-2 M<sup>pro</sup> InhibitorsLeon Jacobs, Aletta van der Westhuyzen, Nicole Pribut, et al.
Journal of Gastroenterology and Hepatology|August 28, 2022
Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort studyDavid Stephen Prince, Glen Schlaphoff, Scott Anthony Davison, et al.
Hepatology International|August 25, 2022
Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort studyKurvi Patwala, David Stephen Prince, Yael Celermajer, et al.
Journal of Translational Medicine|January 10, 2024
Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesisXin Tracy Liu, Yu Huang, Da Liu, et al.
Cell|May 16, 2017
Metabolic Phenotypes of Response to Vaccination in HumansShuzhao Li, Nicole L Sullivan, Nadine Rouphael, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 28, 2023
The incidence of adverse outcome in donors after living donor liver transplantation: A meta-analysis of 60,829 donorsJieling Xiao, Rebecca Wenling Zeng, Wen Hui Lim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2023
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and AdultsAndrew W Lee, Ken Liu, Edouard Lhomme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2025
Discovery of BMS-986365, a first-in-class dual androgen receptor ligand-directed degrader (AR LDD) and antagonist, for the treatment of advanced prostate cancerSurendra Nayak, John D Norris, Massimo Ammirante, et al.
Movement Disorders Clinical Practice|May 2, 2024
Improving Conversations about Parkinson's DementiaIvelina Dobreva, Joanne Thomas, Anne Marr, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 8, 2018
Territory-wide population-based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong KongYee Tak Hui, Grace L H Wong, James Y Y Fung, et al.
Pageof 26